Onglyza MDL Awaiting Approval Status

Introduction

Another heart failure lawsuit filed recently now awaits a nod for from the U.S. Judicial Panel on Multidistrict Litigation for centralization of all federally-filed Onglyza and Kombiglyze XR lawsuits in a single U.S. District Court for coordinated pretrial proceedings. The number of lawsuits filed has already crossed 40 and is expected to eventually grow to include hundreds of similar cases.

The JPML was scheduled to hear oral arguments on January 25, 2018, to decide whether consolidation was necessary or not. The court records show more than 42 product liability lawsuits pending in the federal court system filed by individuals who developed congestive heart failure and other side effects of diabetes drug.

Comments

Your name

Comment

About text formats

Restricted HTML

Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
Lines and paragraphs break automatically.
Web page addresses and email addresses turn into links automatically.